2024 US Elections: Harris, Trump differ on abortion rights, ACA, public health spends; agree on need to cut drug prices

Data Compilation
#PharmaFlow

Pipeline Prospector Aug 2024: Otsuka buys Jnana, Lilly’s market cap gains by over US$ 108 bn post new guidance

Stock Recap
#PipelineProspector

Azithromycin, unspecified form

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

68 API Suppliers, 26 USDMF, 9 CEP/COS, 8 JDMF, 9 EU WC, 12 KDMF, 2 NDC API, 39 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

21 Drugs in Development

21 Drugs in Development

INTERMEDIATES

6 API Suppliers

6 API Suppliers

FINISHED DOSAGE FORMULATIONS

560 FDF Dossiers, 86 FDA Orange Book, 208 Europe, 13 Canada, 28 Australia, 27 South Africa, 198 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SUSPENSION;ORAL - EQ 1GM BASE/PACKET, FOR SUSPENSION;ORAL - EQ 100MG BASE/5ML, FOR SUSPENSION;ORAL - EQ 200MG BASE/5ML, TABLET;ORAL - EQ 250MG BASE, TABLET;ORAL - EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, INJECTABLE;INJECTION - EQ 500MG BASE/VIAL, TABLET;ORAL - EQ 500MG BASE, FOR SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2GM BASE/BOT

RELATED EXCIPIENT COMPANIES

1 Evonik, 4 Rochem International Inc, 20 SPI Pharma, 2 Seqens, 5 DKSH, 1 Jai Radhe Sales, 1 Pharm-RX Chemical, 12 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 ACG Worldwide, 11 Actylis, 1 Aeon Procare, 8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 18 BASF, 1 Clariant, 12 Corel Pharma Chem, 6 DFE Pharma, 2 Finar, 9 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 33 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 1 Lubrizol Life Science Health, 12 Microlex e.U, 1 Nanjing Bold Chemical, 2 Nomisma Healthcare, 2 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 25 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 2 The Dow Chemical Company, 1 Valens Pharmachem, 4 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

79 Fillers, Diluents & Binders, 53 Coating Systems & Additives, 39 Direct Compression, 33 Controlled & Modified Release, 30 Disintegrants & Superdisintegrants, 29 Thickeners and Stabilizers, 25 Granulation, 24 Taste Masking, 18 Chewable & Orodispersible Aids, 18 Lubricants & Glidants, 17 Parenteral, 16 Co-Processed Excipients, 15 Solubilizers, 15 Topical, 11 Film Formers & Plasticizers, 8 API Stability Enhancers, 7 Emulsifying Agents, 5 Empty Capsules, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 Coloring Agents, 2 Surfactant & Foaming Agents

DIGITAL CONTENT

11 DATA COMPILATION #PharmaFlow, 96 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions, 208 Finished Drug Prices, 10 Annual Reports

MARKET PLACE

79 APIs, 38 FDF Dossiers, 1 Intermediates

PATENTS & EXCLUSIVITIES

2 US Patents, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 8 USP, 9 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls download

Filters

Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
26/09/2024	CSPC Pharmaceutical Group	China	CSPC Ouyi Pharmaceutical Co. , Ltd.	302MF10065	Azithromycin	2020-06-08	2020-06-08	No. 88 Yangzi Road, Economic and Technological Development Zone, Shijiazhuang, Hebei, China
26/09/2024	Ercros	Spain	ERCROS S. A.	224MF10053	Azithromycin Hydrate	2012-03-12	2012-03-12	Paseo del Deleite, s/n 28300-Aranjuez, Madrid Spain

List of Drug Master Files (JDMF) for Azithromycin, unspecified form Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Japan (PMDA). Original Data : PMDA Database

Azithromycin, Unspecified Form

Azithromycin, unspecified form

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

68 API Suppliers

26 USDMF

9 CEP/COS

8 JDMF

9 EU WC

12 KDMF

2 NDC API

39 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

21 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

INTERMEDIATES

6 API Suppliers

FINISHED DOSAGE FORMULATIONS

560 FDF Dossiers

86 FDA Orange Book

208 Europe

13 Canada

28 Australia

27 South Africa

198 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SUSPENSION;ORAL - EQ 1GM BASE/PACKET

FOR SUSPENSION;ORAL - EQ 100MG BASE/5ML

FOR SUSPENSION;ORAL - EQ 200MG BASE/5ML

TABLET;ORAL - EQ 250MG BASE

TABLET;ORAL - EQ 600MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

INJECTABLE;INJECTION - EQ 500MG BASE/VIAL

TABLET;ORAL - EQ 500MG BASE

FOR SUSPENSION, EXTENDED RELEASE;ORAL - EQ 2GM BASE/BOT

RELATED EXCIPIENT COMPANIES

1 Evonik

4 Rochem International Inc

20 SPI Pharma

2 Seqens

5 DKSH

1 Jai Radhe Sales

1 Pharm-RX Chemical

12 Gangwal Healthcare

5 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 ACG Worldwide

11 Actylis

1 Aeon Procare

8 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 Avesta Pharma

18 BASF

1 Clariant

12 Corel Pharma Chem

6 DFE Pharma

2 Finar

9 Gangwal Chemicals

7 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

33 Kerry

3 Kima Chemical

6 Lonza Capsugel

1 Lubrizol Life Science Health

12 Microlex e.U

1 Nanjing Bold Chemical

2 Nomisma Healthcare

2 Novo Excipients

2 Pharmatrans-Sanaq

7 Pluviaendo

4 Prachin Chemical

1 Qianhao Chemical (Hebei) Co., Ltd

TABLET;ORAL - EQ 600MG BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons